top of page
  • Matthew Dowd

Dowd Scheffel Addresses CRISPR Appeal in IP Watchdog Article

Dowd Scheffel attorneys authored an article about the pending and highly watched appeal about the Noel Prize-winning CRISPR invention.  The article highlights how the PTAB stands alone in its ruling against CVC’s technology.  Patent offices in Japan, China, and Europe have all affirmed CVC’s patents covering CRISPR technology that can be used in eukaryotic cells.  This article digs into the hard questions of what this decision means in terms of harmonization, global innovation, and other implications beyond that of CRISPR.  The article is authored by Matthew J. Dowd, Robert J. Scheffel, and Elliot Gee.

Comments


Featured Posts
Recent Posts
Archive
bottom of page